Comment Letters
CTeL submits formal regulatory comments to federal agencies including CMS, DEA, and HHS to ensure digital health stakeholders have a voice in the rulemaking process. These comment letters address proposed rules, requests for information, and policy changes that impact telehealth, remote patient monitoring, and health technology.
Recent Comment Letters
- CTeL Submits Comments on CY'26 CMS Physician Fee Schedule
- Public Comments: Section 232 Investigation of Imports in PPE & Medical Supplies
- CTeL Urges DEA to Extend Telehealth Waivers for Prescribing Controlled Substances
- Unpacking the HHS Request for Information (RFI)